LLY compared with MIRM: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

MIRMMirum Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

MIRMMirum Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

MIRM

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±10.9%▲+11.42%×1.05

Q2 FY26±9.3%▼−11.04%×1.18

= impliedLLY realized, solidMIRM realized, hatchedOne scale, both sides: full bar = 16%× = |realized| ÷ impliedSource: market data

May 7 '26

±6.1%

▼−6.50%

×1.07

Q1 FY26±6.9%▼−15.13%×2.19

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

MIRMMirum Pharmaceuticals, Inc.

93.49▼−0.06%· post 93.79

ClosedNov 6 '26

Mkt cap$6.1BRevenue$186MQ3 FY26Revenue$521MFY25

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

MIRMMirum Pharmaceuticals, Inc.

1,360.90▼−0.28%post 1,358.90

Price

93.49▼−0.06%post 93.79

$1.2T

Mkt cap

$6.1B

Q3 FY26$24.4B

Revenue

$186MQ3 FY26

FY25$65.2B

Revenue

$521MFY25

LLY1,360.90▼−0.28%vsMIRM93.49▼−0.06%ClosedNov 6 '26